Memorial Sloan Kettering Cancer Center broke ground on the forthcoming inpatient facility called the Kenneth C. Griffin Pavilion in New York City.
Charles Rudin was appointed director of Memorial Sloan Kettering Cancer Center, effective June 1.
MSK breaks ground on the Kenneth C. Griffin Pavilion
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
Lonny Yarmus was appointed head of the Division of Subspecialty Medicine in the Department of Medicine at Memorial Sloan Kettering Cancer Center. A physician-scientist and internationally recognized leader in interventional pulmonology and procedural innovation, Yarmus is widely known for his expertise in minimally invasive diagnostics and therapeutics, outcomes research, and multidisciplinary program development.
Memorial Sloan Kettering Cancer Center has launched Care Partners of Memorial Sloan Kettering Cancer Center, an MSK initiative of healthcare organizations that are committed to working with MSK toward a shared goal of expanding access to integrated, subspecialized, high-quality cancer care and delivering the latest and most effective cancer treatments to their communities.
Deborah Schrag, a gastrointestinal medical oncologist and George J. Bosl Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center, was elected 2027-28 president of the American Society of Clinical Oncology.
Omar Abdel-Wahab, Andrea Ablasser, and Christina Curtis were named awardees of the 2025 Memorial Sloan Kettering Cancer Center Paul Marks Prize for Cancer Research.
Ross L. Levine was named chief scientific officer at Memorial Sloan Kettering Cancer Center.
